SGK1 and cancer: Since pSGK-1 is the active and the pro-survival form of SGK-1, its reduction in is suggestive of an adaptive mechanism to curtail tumor growth, an aspect of translational relevance in relation to use of SGK-1 inhibitors as therapeutic options in cancer (47).